Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Oncology|August 25, 2005
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932Edith A Perez, Vera J Suman, Tom R Fitch, et al.Clinical Colorectal Cancer|July 7, 2011
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52John S Bolton, Michael J O'Connell, Michelle R Mahoney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7Charles L Loprinzi, Ralph Levitt, Debra Barton, et al.Cytokine|June 18, 2018
A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?K B Casaletto, F M Elahi, R Fitch, et al.Cancer|August 4, 2007
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment GroupAminah Jatoi, Shaker R Dakhil, Phuong L Nguyen, et al.Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.Clinical Breast Cancer|October 23, 2012
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxaneKostandinos Sideras, Amylou C Dueck, Timothy J Hobday, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Allen M Vukov, Thomas M Habermann, et al.Pageof 11